Bain, Cinven Continue Stada Pursuit With Improved $4.7B Bid
Bain Capital and Cinven will make a new, sweetened €4.12 billion ($4.7 billion) takeover offer for Stada Arzneimittel AG, the German pharmaceutical company said Monday, after the private equity shops' previous...To view the full article, register now.
Already a subscriber? Click here to view full article